| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 470 | $130 | $62.2K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 780 | $70 | $55.2K |
| 52000 | In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a… | 210 | $220 | $46.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 320 | $110 | $33.3K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 140 | $160 | $22.1K |
| 55866 | The provider removes the prostate gland through a minimally invasive laparoscopic approach behind the pubic bone. The surgery is radical, meaning the entire prostate is removed, often to treat… | 20 | $1,110 | $21.1K |
| 50545 | The provider removes a kidney including surrounding structures such as Gerota's fascia, nearby lymph nodes, adrenal glands, and fatty tissue. | 10 | $1,250 | $16.2K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 180 | $90 | $15.8K |
| J9155 | Injection, degarelix, 1 mg | 5,200 | $1 | $15.6K |
| 52224 | The provider inspects the urethra, prostatic urethra (in men), the interior of the bladder, and ureteric openings using a cystoscope passed through the urethra and into the bladder; he destroys… | 20 | $750 | $14.3K |